|
KIF20B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.37289999999768E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.75929999996139E-06 |
| Normal-vs-Stage2 |
3.934300E-02 |
| Normal-vs-Stage3 |
1.016670E-03 |
| Normal-vs-Stage4 |
2.02799999999836E-05 |
| Stage1-vs-Stage2 |
3.821200E-01 |
| Stage1-vs-Stage3 |
4.631800E-01 |
| Stage1-vs-Stage4 |
2.417200E-01 |
| Stage2-vs-Stage3 |
7.429000E-01 |
| Stage2-vs-Stage4 |
1.227230E-01 |
| Stage3-vs-Stage4 |
1.011040E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.51309999979676E-07 |
| Normal-vs-AfricanAmerican |
8.525900E-02 |
| Normal-vs-Asian |
1.445710E-02 |
| Caucasian-vs-AfricanAmerican |
9.862500E-03 |
| Caucasian-vs-Asian |
6.388000E-01 |
| AfricanAmerican-vs-Asian |
1.103600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62759999999817E-05 |
| Normal-vs-Female |
1.66689999999692E-05 |
| Male-vs-Female |
3.460600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.415800E-03 |
| Normal-vs-Age(41-60Yrs) |
1.87602999999203E-05 |
| Normal-vs-Age(61-80Yrs) |
3.98219999997451E-06 |
| Normal-vs-Age(81-100Yrs) |
3.281800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.773600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.145400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.416000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.901400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.860500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.146400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.061100E-03 |
| Normal-vs-Grade 2 |
1.47409999995407E-06 |
| Normal-vs-Grade 3 |
2.762200E-04 |
| Normal-vs-Grade 4 |
9.018100E-04 |
| Grade 1-vs-Grade 2 |
9.644600E-01 |
| Grade 1-vs-Grade 3 |
3.417800E-01 |
| Grade 1-vs-Grade 4 |
9.754600E-01 |
| Grade 2-vs-Grade 3 |
5.506100E-02 |
| Grade 2-vs-Grade 4 |
9.950000E-01 |
| Grade 3-vs-Grade 4 |
2.190000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.54020000034494E-07 |
| Normal-vs-ccB subtype |
1.124290E-03 |
| ccA subtype-vs-ccB subtype |
3.691800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.26669999994866E-06 |
| Normal-vs-N1 |
6.220400E-03 |
| N0-vs-N1 |
7.965800E-02 |
|
|
